sellas life sciences group stock

SELLAS Life Sciences Group Inc is a biopharmaceutical company. Common Stock SLS After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.

Sls Stock Is Going Up Leading Indicators Saw It First Sls Slsstock Stocks Trends Marketing Trends Sls Saw

Hot stocks to watch.

. SLS added 7 i n the pre-market after the clinical-stage biotech announced topline data from a Phase. Over the past year the SP 500 is lower by -289 while SLS is down -7053. Lets start up with the current stock price of SELLAS Life Sciences Group Inc.

Technical analysis is hidden due to insufficient data. SELLAS Life Sciences Group Inc NASDAQSLS is active in pre-market trading today May 25 with shares up 1323 from the last closing price. SPY 38963 004 TSLA 66390 -642 SIGA 1240 4335 AAPL 13759 017 NVDA 16694 -251.

About SELLAS Life Sciences Group. We are a global healthcare company with a 125-year history of working to make a difference. Sellas Life Sciences NASDAQ.

SELLAS Life Sciences Group Inc Registered Shs Stock SLS 286 001 035 Official Close 532022 NAS Add to watchlist News Analyst Data Analyst Opinions Insider Activity Dividend Calendar. SELLAS Life Sciences Group Inc. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications.

SLS 312 014 470. SELLAS Life Sciences Group Inc. 1 month ago - Benzinga.

Many many catalysts in place for SLS including a new cancer treatment drug co-developed by MERCK now entering phase III FDA testing. SLS lost -222 per share in the over the last 12. SLS which is 360 to be very precise.

Stock price fell by -321 on the last day Friday 8th Apr 2022 from 374 to 362. SELLAS Life Sciences Stock Plunges After 25M Capital Raise Via Equity In-Licenses Cancer-Focused CDK9 Inhibitor GenFleet Therapeutics has granted GFH009 rights to SELLAS Life Sciences Group Inc NASDAQ. SELLAS Life Sciences Group Inc.

SLS Nasdaq Capital Market Nasdaq SLS 705 064 100 Price as of. SLS Stock Price News Info The Motley Fool SELLAS Life Sciences Group Inc. Red day on Friday for SELLAS Life Sciences Group Inc stock after losing 0 Updated on May 20 2022 Notice.

Biopharmaceutical veteran brings more than 25 years of experience to sellasnew york march 14 2022 globe newswire -- sellas life sciences group inc. During the day the stock fluctuated 484 from a day low at 351 to a day high of 368. SELLAS Life Sciences Group Stock Forecast Price News 302 -002 -066 As of 04222022 1200 AM ET Todays Range 294 318 50-Day Range 302 718 52-Week Range 294 1508 Volume 190858 shs Average Volume 235764 shs Market Capitalization 4804 million PE Ratio NA Dividend Yield NA Beta 143 Profile Analyst Ratings Chart.

Is a late-stage clinical biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications. SELLAS Life Sciences plunged 24 on 25M stock offering SA NewsFri Apr. Additional round of S-1 financing was completed in under FOUR days.

SELLAS Life Sciences Group Inc NASDAQ Updated May 18 2022 900 PM. The Stock rose vividly during the last session to 368 after opening rate of 310 while the lowest price it went was recorded 308 before closing at 312Recently in News on May 12 2022 SELLAS Life Sciences Reports First Quarter 2022. The stock is down 4394 year-to-date and posted 403.

Click to get the best stock tips daily for free. SELLAS Life Sciences Group Inc. SELLAS Life Sciences Group Inc.

01 4 Comments Sellas Life Sciences licenses CDK9 inhibitor from Chinas GenFleet Therapeutics SA NewsThu Mar. Get Sellas Life Sciences Group Inc SLSNASDAQ real-time stock quotes news price and financial information from CNBC. Is a clinical stage biopharmaceutical company which engages in the development and commercialization of immunotherapeutic for.

Get the latest Sellas Life Sciences Group Inc SLS real-time quote historical performance charts and other financial information to help you make more. The SELLAS Life Sciences Group Inc. The Companys lead product candidate galinpepimut-S GPS is a cancer immunotherapeutic agent licensed from Memorial Sloan.

Sellas Life Sciences Group Inc SLS stock has fallen -472 while the SP 500 has gained 222 as of 119 PM on Thursday May 26. SLS is down -015 from the previous closing price of 318 on volume of 442975 shares. SELLAS Life Sciences Group Inc.

Common Stock SLS Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. SLS across all therapeutic and diagnostic uses worldwide outside of Greater China mainland China Hong Kong. The price has fallen in 8 of the last 10 days and is down by -4692 for this period.

SELLAS Life Sciences Group Inc.

Sls Stock Is Going Up Leading Indicators Saw It First Sls Slsstock Stocks Trends Marketing Trends Sls Saw